Skip to main content

Table 1 Demographic and clinical characteristics of study patients

From: Earlobe arterialized capillary blood gas analysis in the intensive care unit: a pilot study

Patients

55

  Male

40 (72.7%)

  Age in years

63 (24 to 83)

  Arterial hypertension

23 (41.8%)

  Diabetes mellitus

19 (34.5%)

  Chronic cardiac failure

4 (7.3%)

  Severe vasculopathy

4 (7.3%)

  Renal insufficiency

5 (9.1%)

Diagnostic at ICU admission

 

  Severe sepsisa

21 (38.1%)

  Respiratory failure

7 (12.7%)

  Severe trauma

7 (12.7%)

  Neurological

6 (10.8%)

Cardiogenic shock

5 (9.1%)

  Miscellaneous

9 (16%)

Clinical variables

 

  PEEP (cmH2O)

7.1 (4 to 12)

  FiO2

0.36 (0.21 to 0.66)

  Minute volume (L/min)

9 (5.5 to 19)

  APACHE II

18.3 (3 to 34)

  Mean arterial pressure (mmHg)

80 (57 to 113)

  Cardiac index (L/min/m2)

3.2 (1 to 5.9)

  Arterial lactate (mg/dl)

18.7 (6 to 71)

  Arterial lactate > 22 mg/dl

10 (18%)

  Sepsisa

32 (58.2%)

  Platelets (× 103/dl)

226 (54 to 669)

  Prothrombin time (ratio)

1.2 (1 to 1.9)

  Prophylactic anticoagulant

40 (72.7%)

  Antiplatelet treatment

6 (10.9%)

  Vasoactive treatment

36 (65.5%)

  NE

30 (83.3%)

  NE dose (μg/kg/min)

0.49 (0.02 to 3.02)

  Other vasoconstriction treatment

3 (8.2%)

  Inotropic treatment

5 (13.8%)

  Vasodilation treatment

2 (5.5%)

  1. Data reported as mean (range), except where% is shown in which case values illustrate ‘incidence’. APACHE II, Acute Physiology and Chronic Health Evaluation II score; NE, norepinephrine; PEEP, positive end expiratory pressure.
  2. aFollowing Surviving Sepsis Campaign Guidelines [17].